Historical record - last NADAC effective date: 4/5/2019
Product Information
MIRVASO 0.33% GEL is a brand product labeled by Galderma Laboratories, L.P., priced at $16.1504 per GM under NDC 00299598030. Its NADAC has been published 331 times since Dec 18, 2013.
FDA first approved this application on Aug 23, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the brimonidine tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/g
Manufacturer
Galderma Laboratories, L.P.NDC
00299598030
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
4/5/2019
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA204708FDA Approved
8/23/2013
TE Code
AB
On Market Since
8/23/2013
Pharmacological Classes
Price Statistics
The NADAC for MIRVASO 0.33% GEL has been published 331 times since Dec 18, 2013, and over the history we have for it it has risen 103.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.1504 per GM |
|---|---|
| All-time high | $16.1504 (Apr 15, 2020) |
| All-time low | $7.9371 (Dec 18, 2013) |
| Median price | $12.7472 |
| Average price | $12.6718 |
| Largest weekly change | +20.0% (Sep 9, 2015) |
| Weeks tracked | 331 |
| Tracking since | Dec 18, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+103.5%
Last surveyed Apr 15, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIRVASO 0.33% GEL?
The current National Average Drug Acquisition Cost (NADAC) for MIRVASO 0.33% GEL, manufactured by Galderma Laboratories, L.P., is $16.1504 per GM (NDC 00299598030), effective Apr 15, 2020.
How has the price of MIRVASO 0.33% GEL changed over time?
Over the history we have for it, the NADAC for MIRVASO 0.33% GEL has risen 103.5%. It has been tracked across 331 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for MIRVASO 0.33% GEL?
Since Dec 18, 2013, the NADAC for MIRVASO 0.33% GEL has ranged from a low of $7.9371 (Dec 18, 2013) to a high of $16.1504 (Apr 15, 2020), with a median of $12.7472 per GM.
Are there cheaper alternatives to MIRVASO 0.33% GEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MIRVASO 0.33% GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures MIRVASO 0.33% GEL?
MIRVASO 0.33% GEL (NDC 00299598030) is labeled by Galderma Laboratories, L.P., and CMS classifies it as a brand product.